PEAK6 Investments’s Acceleron Pharma XLRN Stock Holding History

PEAK6 Investments’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,581	Closed	-$616K	–	6132
2021 Q3	$616K	Buy	3,581 +1,817	+103%	+$238K	﹤0.01%	3045
2021 Q2	$221K	Sell	1,764 -4,041	-70%	-$510K	﹤0.01%	3951
2021 Q1	$787K	Buy	5,805 +4,920	+556%	+$636K	﹤0.01%	2787
2020 Q4	$113K	Buy	885 +787	+803%	+$92.3K	﹤0.01%	3995
2020 Q3	$11K	Buy	+98	New	+$9.76K	﹤0.01%	4179

PEAK6 Investments's XLRN Position: Q4 2021 in Review

PEAK6 Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,581 shares — an estimated $616K sold.

PEAK6 Investments first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $787K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

PEAK6 Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
PEAK6 Investments sold 3,581 Acceleron Pharma shares in Q4 2021, an estimated $616K.
PEAK6 Investments first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
PEAK6 Investments's Acceleron Pharma position peaked at $787K in Q1 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on PEAK6 Investments's 13F filing for Q4 2021, filed 11 Feb 2022.